武汉华尔生物科技

Wuhan Huaer Biotechnology is a specialized medical technology company focused on the development and manufacturing of in vitro diagnostic (IVD) solutions. The company primarily operates within the Point-of-Care Testing (POCT) sector, utilizing advanced fluorescence immunoassay and colloidal gold platforms. Their product portfolio encompasses a wide range of rapid test kits and automated analyzers designed for cardiac markers, inflammatory indicators, and chronic disease management. Headquartered in Wuhan's Optics Valley, the firm provides integrated diagnostic systems to healthcare providers to improve clinical efficiency and patient outcomes. Wuhan Huaer Biotechnology maintains rigorous quality standards, holding various international certifications for its manufacturing processes and diagnostic products.